Inventor · disambiguated record
Jerome J. Schentag
Also filed as: SCHENTAG JEROME · SCHENTAG JEROME J
26 granted patents·19 pending applications·1,836 citations·filing 1991–2024
96Inventor score
Files withTHERASYN SENSORS INC10VOLANT HOLDINGS GMBH9THERABIOME LLC7SCHENTAG JEROME J4SCHENTAG JEROME3
Top patents by PatentIndex Score
45 records- 0195US5395366ASampling capsule and processUNIV NEW YORK·Filed 1994·Granted Mar 7, 1995·593 cites·55 claims
- 0294US5279607ATelemetry capsule and processUNIV NEW YORK·Filed 1991·Granted Jan 18, 1994·1.1k cites·55 claims
- 0392US12005146B2Methods of treatment using cholestosome vesicles for incorporation of molecules into chylomicronsTHERASYN SENSORS INC·Filed 2023·Granted Jun 11, 2024·1 cites·20 claims
- 0492US11052052B2Cholestosome vesicles for incorporation of molecules into chylomicronsTHERASYN SENSORS INC·Filed 2019·Granted Jul 6, 2021·6 cites·30 claims
- 0590US9907755B2Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agentsTHERABIOME LLC·Filed 2014·Granted Mar 6, 2018·13 cites·20 claims
- 0689US10369114B2Cholestosome vesicles for incorporation of molecules into chylomicronsTHERASYN SENSORS INC·Filed 2017·Granted Aug 6, 2019·8 cites·30 claims
- 0789US9370528B2Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a hepatitis C virus infectionSCHENTAG JEROME·Filed 2012·Granted Jun 21, 2016·22 cites·51 claims
- 0888US10624913B2Diagnostics and methods for treatment of non-alcoholic hepatic steatosis and hepatic steatohepatitis, and prevention of complications thereofVOLANT HOLDINGS GMBH·Filed 2018·Granted Apr 21, 2020·3 cites·20 claims
- 0988US8367418B2Method and system to provide personalized pharmaceutical compositions and dosagesTHERASYN SENSORS INC·Filed 2010·Granted Feb 5, 2013·10 cites·4 claims
- 1087US12465575B2Methods of treatment using cholestosome vesicles for incorporation of molecules into chylomicronsTHERASYN SENSORS INC·Filed 2024·Granted Nov 11, 2025·0 cites·19 claims
- 1186US9443060B2Method and system to provide personalized pharmaceutical compositions and dosagesVOLANT HOLDINGS GMBH·Filed 2015·Granted Sep 13, 2016·4 cites·10 claims
- 1286US9103766B2Device and method for monitoring and quantifying analytesUNIV NEW YORK STATE RES FOUND·Filed 2012·Granted Aug 11, 2015·5 cites·11 claims
- 1386US8999721B2Method and system to provide personalized pharmaceutical compositions and dosagesTHERASYN SENSORS INC·Filed 2013·Granted Apr 7, 2015·7 cites·8 claims
- 1485US7326387B2Air decontamination devicesARTS THEODORE A M·Filed 2003·Granted Feb 5, 2008·65 cites·47 claims
- 1581US9730951B2Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a Hepatitis C virus infectionVOLANT HOLDINGS GMBH·Filed 2016·Granted Aug 15, 2017·3 cites·39 claims
- 1680US10369111B2Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agentsTHERABIOME LLC·Filed 2018·Granted Aug 6, 2019·2 cites·20 claims
- 1778US9693968B2Cholestosome vesicles for incorporation of molecules into chylomicronsSCHENTAG JEROME J·Filed 2014·Granted Jul 4, 2017·5 cites·26 claims
- 1878US2023277468A1Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agentsTHERABIOME LLC·Filed 2023·Application pending·0 cites
- 1977US10588857B2Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendixTHERABIOME LLC·Filed 2013·Granted Mar 17, 2020·3 cites·18 claims
- 2075US11633364B2Methods of treatment using cholestosome vesicles for incorporation of molecules into chylomicronsTHERASYN SENSORS INC·Filed 2021·Granted Apr 25, 2023·0 cites·15 claims
- 2174US10245277B2Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a hepatitis C virus infectionVOLANT HOLDINGS GMBH·Filed 2017·Granted Apr 2, 2019·1 cites·18 claims
- 2271US2022400937A1Wireless vaginal capsule and methods for monitoring fertility and pregnancyTHERASYN SENSORS INC·Filed 2022·Application pending·0 cites
- 2369US9216106B2Device and method for the delivery of drugs for the treatment of posterior segment diseaseSCHULTZ CLYDE L·Filed 2008·Granted Dec 22, 2015·2 cites·23 claims
- 2469US6485714B1Use of salicylic acid for regulating hyperpigmented spotsBRADFORD SHERRY A·Filed 2000·Granted Nov 26, 2002·10 cites·13 claims
- 2569US2023240997A1Method of treating cancerTHERASYN SENSORS INC·Filed 2022·Application pending·0 cites
- 2667US2024374526A1Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agentsTHERABIOME LLC·Filed 2024·Application pending·0 cites
- 2764US11590083B2Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agentsTHERABIOME LLC·Filed 2019·Granted Feb 28, 2023·0 cites·14 claims
- 2863US10349820B2Device and methods for in vivo monitoring of an individualSCHENTAG JEROME J·Filed 2011·Granted Jul 16, 2019·2 cites·22 claims
- 2962US11622936B2Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendixTHERABIOME LLC·Filed 2020·Granted Apr 11, 2023·0 cites·19 claims
- 3061US2019298804A1Activation of the endogenous ileal brake hormone pathway for organ regeneration and related compositions, methods of treatment, diagnostics, and regulatory systemsVOLANT HOLDINGS GMBH·Filed 2018·Application pending·0 cites
- 3160US2020069161A1Wireless vaginal capsule and methods for monitoring fertility and pregnancyTHERASYN SENSORS INC·Filed 2019·Application pending·0 cites
- 3254US2014294951A1Oral formulations mimetic of Roux-en-Y gastric bypass actions on the ileal brake; Compositions, methods of treatment, diagnostics and systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hyperlipidemia, and T2DFAYAD JOSEPH M·Filed 2012·Application pending·0 cites
- 3354US2018099001A1Diagnostics and methods for treatment of non-alcoholic hepatic steatosis and hepatic steatohepatitis, and prevention of complications thereofVOLANT HOLDINGS GMBH·Filed 2017·Application pending·0 cites
- 3453US2015377860A1Device and Method for Monitoring and Quantifying AnalytesBREATH DIAGNOSTICS LLC·Filed 2015·Application pending·0 cites
- 3553US2019175515A1Cholesteryl ester vesicles loading peptides, proteins and nucleic acids into chylomicrons and body cellsSCHENTAG JEROME J·Filed 2017·Application pending·0 cites
- 3652US12343374B2Enhancement of antibacterial actions of a depsipeptide antibiotic using synergistic amounts of boric acidKYOTO BIOPHARMACEUTICALS INC·Filed 2019·Granted Jul 1, 2025·0 cites·15 claims
- 3752US2017007631A1Oral formulations Mimetic of Roux-en-Y gastric bypass actions on the ileal brake; Compositions, Methods of Treatment, Diagnostics and Systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hyperlipidemia, and T2DVOLANT HOLDINGS GMBH·Filed 2016·Application pending·0 cites
- 3848US2019262367A1Oral formulations mimetic of roux-en-y gastric bypass actions on the ileal brake; compositions, methods of treatment, diagnostics and systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hyperlipidemia, and type 2 diabetesVOLANT HOLDINGS GMBH·Filed 2018·Application pending·0 cites
- 3948US2015352189A1Activation of the endogenous ileal brake hormone pathway for organ regeneration and related compositions, methods of treatment, diagnostics, and regulatory systemsSCHENTAG JEROME·Filed 2014·Application pending·0 cites
- 4043US2013273154A1Oral formulations Mimetic of Roux-en-Y gastric bypass actions on the ileal brake; Compositions, Methods of Treatment, Diagnostics and Systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hpperlipidemia, and type 2 diabetesFAYAD JOSEPH M·Filed 2012·Application pending·0 cites
- 4143US2017014436A1Oral formulations Mimetic of Roux-en-Y gastric bypass actions on the ileal brake; Compositions, Methods of Treatment, Diagnostics and Systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hyperlipidemia, and type 2 diabetes.VOLANT HOLDINGS GMBH·Filed 2016·Application pending·0 cites
- 4239US2013237774A1Device and Method for Continuous Chemical SensingSCHENTAG JEROME J·Filed 2011·Application pending·0 cites
- 4337US2016158320A1Device and method for the delivery of drugs for the treatment of posterior segment diseaseDIRECT CONTACT LLC·Filed 2015·Application pending·0 cites
- 4435US2017173060A1Activation of the endogenous ileal brake hormone pathway for organ regeneration and related compositions, methods of treatment, diagnostics, and regulatory systemsSCHENTAG JEROME·Filed 2017·Application pending·0 cites
- 4532US2010179397A1Device And Method For Continuous Monitoring Of A Chemical Parameter Of An IndividualBRIGHT FRANK V·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jerome J. Schentag files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →